GeoVax enters $30 million revolving credit agreement
GeoVax Labs, Inc. signed a five-year $30 million revolving loan facility with a public limited hedge fund, enabling the company to borrow funds as needed. This capital is intended to fund working capital and general corporate purposes, strengthening the company's financial position.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed